Vision relies on two distinct cell populations in the retina — rods for dim conditions, cones for bright light and colour — and ‘rod-cone dystrophy’ simply identifies which one begins failing first. In this category, the rods go first, with cone involvement following later, and that particular sequence describes the overwhelming majority of what’s clinically diagnosed as retinitis pigmentosa. Recognising the order matters practically, because it lets us anticipate fairly reliably which visual functions are likely to decline earliest and which are likely to hold on longest.
Patients who arrive at a retina clinic in India with ‘rod-cone dystrophy’ already noted on a referral slip often have little idea what the phrase actually means for them day to day. Walking through that rod-first sequence at the outset tends to clear up more confusion than further testing alone would.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
“There’s considerable overlap between the two labels. ‘Rod-cone dystrophy’ refers to the sequence the disease follows — rods first, cones second — and that sequence accounts for the majority of what gets clinically diagnosed as retinitis pigmentosa.
”
”
It comes down to which cell type is affected first. Rod-cone dystrophy hits night and side vision early while central and colour vision hold up longer; cone-rod dystrophy runs the opposite way, affecting central and colour vision sooner.
”
” For many patients with rod-cone dystrophy, yes, eventually — once the disease has advanced enough to involve the cones. Exactly when that happens varies considerably depending on the gene involved and the individual patient.”
“That’s decided case by case, based on how your ERG and visual field results trend after the initial evaluation. Some patients do fine with an annual review, while others whose condition is shifting faster are followed more closely.”
